clenbuterol has been researched along with Cardiomyopathies in 5 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol is a potent beta-2 agonist widely misused by professional athletes and bodybuilders." | 3.01 | Adverse events of clenbuterol among athletes: a systematic review of case reports and case series. ( Kumari, S; Pal, B; Prabhakar, PK; Sahu, SK; Tewari, D, 2023) |
| "Clenbuterol treatment in MLP(-/-) mice was associated with significant changes in the following circulating factors: tissue inhibitor of metalloproteinase-type 1, leukemia inhibitory factor 1, C-reactive protein, apolipoprotein A1, fibroblast growth factor 2, serum glutamic oxaloacetic transaminase, macrophage-derived chemokine, and monocyte chemoattractant protein-3." | 1.35 | Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy. ( Adhikari, N; Barton, PJ; Birks, EJ; Charles, NJ; Hall, JL; Lee, S; Mariash, A; Miller, LW; Polster, SP; Rider, JE; Smolenski, RT; Stangland, J; Tadros, G; Terracciano, CM; Yacoub, MH, 2009) |
| "Clenbuterol was identified in the blood and or urine of 12 of these 13 patients." | 1.35 | A descriptive study of an outbreak of clenbuterol-containing heroin. ( Hoffman, RS; Kirrane, BM; Marcus, SM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumari, S | 1 |
| Pal, B | 1 |
| Sahu, SK | 1 |
| Prabhakar, PK | 1 |
| Tewari, D | 1 |
| Rider, JE | 2 |
| Polster, SP | 1 |
| Lee, S | 1 |
| Charles, NJ | 1 |
| Adhikari, N | 1 |
| Mariash, A | 1 |
| Tadros, G | 1 |
| Stangland, J | 1 |
| Smolenski, RT | 1 |
| Terracciano, CM | 1 |
| Barton, PJ | 2 |
| Birks, EJ | 2 |
| Yacoub, MH | 2 |
| Miller, LW | 2 |
| Hall, JL | 2 |
| Maybaum, S | 1 |
| Grindle, S | 1 |
| Latif, N | 1 |
| Hardy, JP | 1 |
| Banner, NR | 1 |
| Khaghani, A | 1 |
| Hoffman, RS | 1 |
| Kirrane, BM | 1 |
| Marcus, SM | 1 |
1 review available for clenbuterol and Cardiomyopathies
| Article | Year |
|---|---|
Adverse events of clenbuterol among athletes: a systematic review of case reports and case series.
Topics: Adrenergic beta-Agonists; Cardiomyopathies; Clenbuterol; Humans; Myocardial Infarction; Myocardial I | 2023 |
4 other studies available for clenbuterol and Cardiomyopathies
| Article | Year |
|---|---|
Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Apolipoprotein A-I; Aspartat | 2009 |
Cardiac recovery during continuous-flow left ventricular assist device support: some good news from across the Atlantic.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Clenbuterol; Clinical Protocols; Clin | 2011 |
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Cardiovascul | 2005 |
A descriptive study of an outbreak of clenbuterol-containing heroin.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Clenbuterol; Disease Outbreaks; Drug | 2008 |